Global In Vitro Diagnostics Market: Snapshot 

In Vitro Diagnostics are medical devices that are used to carry out tests on human samples, (e.g., tissue, urine, and blood) in order to: diagnose medical conditions, regulate drug therapies prevent diseases, or diagnose infections. The devices ranges from simple tests to sophisticated DNA technology including calibrators, reagents, kits, software, control materials, and related instruments. Some test are performed at diagnostics laboratories or hospitals while some are performed at home. In vitro diagnostics add significant value to diagnosis of disease and treatment procedure, enhancing the quality of life.

in vitro diagnostics market

Clinical Chemistry to Witness Highest Demand among Technology Segments

The market for in vitro diagnostics have been broadly segmented into technology type, applications, and end user. By technology type market further segmented into point of care, molecular diagnostics, immunoassays, clinical chemistry, whole blood glucose monitoring, hematology, clinical microbiology, coagulation and hemostasis, and others. Of these, clinical chemistry held dominance, with a share of 25.2% in the global market in 2016. However, molecular diagnostics offer more accurate diagnosis of infections, which is why their demand is likely to accelerate at a faster pace in the coming years. On the basis of applications in vitro diagnostics market has been segmented as drug testing, infectious disease, oncology, metabolic disease, autoimmune disease, and others. Further the market has been segmented according to its end users that includes diagnostics laboratories, hospitals, academic & research centers, home care and others.

The market is driven by the rising incidence rates of infectious and chronic diseases such as human immunodeficiency infection and chronic obstructive pulmonary disease, diabetes and cancer. Some of the other factors driving the market are rising global healthcare expenditure and increasing demand for rapid, minimally invasive and non-invasive diagnostic procedures, increased availability of over-the-counter tests, and improved treatment monitoring. Complicated and limited availability of reimbursement options will restrain the growth of the market. The rise of epigenomics-based diagnostics tools is expected to drive the in vitro diagnostics market in the future. The proficiency of molecular diagnostics to identify disease condition at an early stage of development will also fuel the future growth of the market.

US in North America to Emerge as One of the Most Lucrative Markets

By geography, global in vitro diagnostics market has been segmented into major five region: North America, Europe, Asia, Latin America and Rest of World. In 2016, North America and Europe accounted for the largest share of the global in vitro diagnostics market followed by Asia, Latin America, and Middle East & Africa. The U.S. dominated the In Vitro Diagnostics Market in North America, accounting for the majority share in 2016. This dominance is majorly due factors such as technological advancements, well-structured healthcare system, extensive R&D practices and increasing healthcare awareness are driving market growth. However, Europe is growing at slow rate while Asia is anticipated to witness the fastest CAGR during the forecast period with major contribution of countries such as China, India, and Japan. New product launches, presence of a large patient pool, increasing healthcare expenditure, ability of patients to pay for advanced technology products, and growing awareness are likely to drive the market in Asia during the forecast period.

The key players operating in the in vitro diagnostics market are Abbott., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Gen-Probe Incorporated, Ortho Clinical Diagnostics, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers (a division of Siemens AG), Sysmex Corporation, Qiagen N.V., Diasorin and Thermo Fisher Scientific Corporation. The global in vitro diagnostics market is dominated only by few players such as F. Hoffmann-La Roche Ltd and Abbott that operates global market. 

Global In Vitro Diagnostics Market: Overview

This report on in vitro diagnostics market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing in vitro diagnostics products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global in vitro diagnostics market with respect to the leading market segments based on major types, applications, end users, and geographies.

Global In Vitro Diagnostics Market: Key Segments

By technology type market further segmented into point of care, molecular diagnostics, immunoassays, clinical chemistry, whole blood glucose monitoring, hematology, clinical microbiology, coagulation and hemostasis, and others. On the basis of applications in vitro diagnostics market has been segmented as drug testing, infectious disease, oncology, metabolic disease, autoimmune disease, and others. Further the market has been segmented according to its end users that includes diagnostics laboratories, hospitals, academic & research centers, home care and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, and technological advancement, in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the in vitro diagnostics market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global in vitro diagnostics market.

Global In Vitro Diagnostics Market: Regional Outlook

Geographically, in vitro diagnostics market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global In Vitro Diagnostics Market.

Companies Mentioned in Report

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global In Vitro Diagnostics Market. The key players operating in the in vitro diagnostics market are Abbott., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Gen-Probe Incorporated, Ortho Clinical Diagnostics, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers (a division of Siemens AG), Sysmex Corporation, Qiagen N.V., Diasorin and Thermo Fisher Scientific Corporation. The global in vitro diagnostics market is dominated only by few players such as F. Hoffmann-La Roche Ltd and Abbott that operates global market. 

The global In Vitro Diagnostics Market is segmented as follows:

Global In Vitro Diagnostics Market, by Technology

  • Point of Care
  • Molecular Diagnostics
    • Polymerase Chain Reaction(PCR)
    • Isothermal Nucleic Acid Amplification Technology
    • Microarray
    • Hybridization
    • DNA Sequencing and Next Generation Sequencing
    • Other MDX Technologies
  • Immunoassay
    • Enzyme-Linked Immunosorbent Assays (ELISA)
    • Radioimmunoassay (RIA)
    • Enzyme-Linked Immunospot (ELIspot) Assay
    • Rapid Tests
    • Other Immunoassay Techniques
  • Clinical Chemistry
    • Basic Metabolic Profile
    • Electrolyte Panel
    • Liver Panel
    • Lipid Panel
    • Renal Panel
    • Thyroid Function Panel
    • Specialty Chemical Tests
  • Whole Blood Glucose Monitoring
  • Hematology
  • Clinical Microbiology
  • Coagulation and Hemostasis
  • Others

Global In Vitro Diagnostics Market, by Application

  • Drug Testing
  • Infectious Disease
  • Oncology
  • Metabolic Disease
  • Autoimmune Disease
  • Others

Global In Vitro Diagnostics Market, by End User

  • Diagnostics Laboratories
  • Hospitals
  • Academic & Research Centers
  • Home Care
  • Others

Global In Vitro Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
.